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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of a health claim related to 
a combination of lycopene, vitamin E, lutein and selenium and protection of 
the skin from UV-induced (including photo-oxidative) damage 
pursuant to Article 13(5) of Regulation (EC) No 1924/2006
1 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following  an  application  from  Nutrilinks  Sarl,  submitted  pursuant  to  Article  13(5)  of  Regulation  (EC)  No 
1924/2006  via  the  Competent  Authority  of  Cyprus,  the  Panel  on  Dietetic  Products,  Nutrition  and  Allergies 
(NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to a combination 
of  lycopene,  vitamin E,  lutein  and  selenium  and  protection  of  the  skin  from  UV-induced  (including  photo-
oxidative) damage. The Panel considers that the combination of lycopene, vitamin E, lutein and selenium is 
sufficiently characterised. The claimed effect refers to the photo-protective activity of the food, delaying the 
appearance  of  UV-induced  erythema  and  decreasing  its  intensity.  The  target  population  proposed  by  the 
applicant is healthy adults in the general population, and in particular people with sensitive skin. The Panel 
considers  that  protection  of  the  skin  from  UV-induced  (including  photo-oxidative)  damage  is  a  beneficial 
physiological effect. The applicant identified one bioequivalence study as being pertinent to the health claim. The 
Panel  notes  that  this  study  did  not  assess  direct  measures  of  UV-induced  (including  photo-oxidative)  skin 
damage. Therefore, no conclusions could be drawn from this study for the scientific substantiation of the claim. 
The Panel concludes that a cause and effect relationship has not been established between the consumption of a 
combination of lycopene, vitamin E, lutein and selenium and protection of the skin from UV-induced (including 
photo-oxidative) damage. © European Food Safety Authority, 2012 
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SUMMARY 
Following an application from Nutrilinks Sarl, submitted pursuant to Article 13(5) of Regulation (EC) 
No 1924/2006 via the Competent Authority of Cyprus, the Panel on Dietetic Products, Nutrition and 
Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim 
related to a combination of lycopene, vitamin E, lutein and selenium and protection of the skin from 
UV-induced (including photo-oxidative) damage. 
The scope of the application was proposed to fall under a health claim based on newly developed 
scientific evidence. 
The food that is the subject of the health claim is a combination of lycopene, vitamin E, lutein and 
selenium.  These  components  are  well-characterised  and  can  be  analysed  in  foods  by  established 
methods. The Panel considers that the combination of lycopene, vitamin E, lutein and selenium is 
sufficiently characterised. 
The claimed effect refers to the photo-protective activity of the food, delaying the appearance of 
UV-induced erythema and decreasing its intensity. The target population proposed by the applicant is 
healthy  adults  in  the  general  population,  and  in  particular  people  with  sensitive  skin.  The  Panel 
considers  that  protection  of  the  skin  from  UV-induced  (including  photo-oxidative)  damage  is  a 
beneficial physiological effect. 
The applicant identified one human intervention study as being pertinent to the health claim. 
This  double-blind,  parallel,  10-week  study  was  a  bioequivalence  study  of  two  oral  “antioxidant 
formulas”  and  their  purported  protective  effects  against  UV  radiation.  Fifty  Caucasian  men  and 
women took a placebo for three weeks (i.e. run-in period) and were then randomised to receive for 
seven further weeks either a supplement designated as “current formula” (6 mg lycopene, 6 mg beta-
carotene, 10 mg vitamin E and 75 µg selenium), or the food which is the subject of the health claim 
(“new formula”). Outcome measures of the study were minimal erythemal dose, Individual Typology 
Angle (i.e. colorimetric measurements), melanin content (i.e. percentage of epidermis occupied by 
melanin) and “capping” (i.e. assembling of melanosomes at keratinocytes’ upper poles). 
The Panel notes that erythema is an inflammatory response of the skin to UV-induced molecular and 
cellular damage. A reduction in UV-induced erythema (e.g. measured as change in minimal erythemal 
dose or erythema grade) may indicate less UV-induced damage to the skin, but it can also reflect a 
reduction  in  the  capacity  of  the  skin  to  react  to  molecular  and  cellular  damage.  Therefore,  UV-
induced erythema cannot be used alone as an outcome measure for the substantiation of the claim. 
The other outcomes (i.e. Individual Typology Angle, melanin content and “capping”) used in the 
study did not provide any information on UV-induced skin damage. 
The  Panel  notes  that  the  submitted  study  was  a  bioequivalence  study  that  did  not  assess  direct 
measures  of  UV-induced  (including  photo-oxidative)  skin  damage.  The  Panel  considers  that  no 
conclusions can be drawn from this study for the scientific substantiation of the claim. 
The  Panel  notes  that  no  studies  were  provided  from  which  conclusions  could  be  drawn  for  the 
scientific substantiation of the claim. 
The  Panel  concludes  that  a  cause  and  effect  relationship  has  not  been  established  between  the 
consumption of a combination of lycopene, vitamin E, lutein and selenium and protection of the skin 
from UV-induced (including photo-oxidative) damage. Lycopene, vitamin E, lutein and selenium and 
protection of the skin from UV-induced damage 
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BACKGROUND 
Regulation (EC) No 1924/2006
3 harmonises the provisions that relate to nutrition and health claims , 
and establishes rules governing the Community authorisation of health claims made on foods.  As a 
rule, health claims are prohibited unless they comply with the general and specific requirements of  
this Regulation, are authorised in accordance with this Regulation , and are included in the lists of 
authorised claims provided for in Articles 13 and 14 thereof. In particular,   Article 13(5) of this  
Regulation lays down provisions for the addition of claims (other than those referring to the reduction 
of disease risk and to chi ldren’s  development  and  health)  which  are  based  on  newly  developed 
scientific  evidence,  or  which  include  a  request  for  the  protection  of  proprietary  data,  to  the 
Community list of permitted claims referred to in Article 13(3). 
According to Article 18 of this Regulation, an application for inclusion in the Community list of 
permitted  claims  referred  to  in  Article  13(3)  shall  be  submitted  by  the  applicant  to  the  national 
competent authority of a Member State, which will make the application and any supplementary 
information supplied by the applicant available to the European Food Safety Authority (EFSA). 
STEPS TAKEN BY EFSA   
  The application was received on 21/05/2012. 
  The  scope  of  the  application  was  proposed  to  fall  under  a  health  claim  based  on  newly 
developed scientific evidence. 
  The scientific evaluation procedure started on 30/06/2012. 
  During  its  meeting  on  13/09/2012,  the  NDA  Panel,  having  evaluated  the  data  submitted, 
adopted an opinion on the scientific substantiation of a health claim related to a combination 
of  lycopene,  vitamin E,  lutein  and  selenium  and  protection  of  the  skin  from  UV-induced 
(including photo-oxidative) damage. 
TERMS OF REFERENCE 
EFSA  is  requested  to  evaluate  the  scientific  data  submitted  by  the  applicant  in  accordance  with 
Article 16(3) of Regulation (EC) No 1924/2006. On the basis of that evaluation, EFSA will issue an 
opinion  on  the  scientific  substantiation  of  a  health  claim  related  to:  a  combination  of  lycopene, 
vitamin E,  lutein  and  selenium  and  protection  of  the  skin  from  UV-induced  (including  photo-
oxidative) damage. 
EFSA DISCLAIMER 
The  present  opinion  does  not  constitute,  and  cannot  be  construed  as,  an  authorisation  for  the 
marketing of a combination of lycopene, vitamin E, lutein and selenium, a positive assessment of its 
safety, nor a decision on whether a combination of lycopene, vitamin E, lutein and selenium is, or is 
not,  classified  as  a  foodstuff.  It  should  be  noted  that  such  an  assessment  is  not  foreseen  in  the 
framework of Regulation (EC) No 1924/2006. 
It should also be highlighted that the scope, the proposed wording of the claim, and the conditions of 
use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation 
procedure foreseen in Article 18(4) of Regulation (EC) No 1924/2006. 
                                                       
3  Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25. Lycopene, vitamin E, lutein and selenium and 
protection of the skin from UV-induced damage 
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INFORMATION PROVIDED BY THE APPLICANT 
Applicant’s name and address: Nutrilinks Sarl, Chemin de Beau-rivage 7, P.O. Box 96, CH-1000 
Lausanne 21, Switzerland. 
Food/constituent as stated by the applicant 
According to the applicant, a food supplement containing lycopene (8 mg), vitamin E (10 mg), lutein 
(1 mg) and selenium (50 µg). 
Health relationship as claimed by the applicant 
According  to  the  applicant,  the  health  claim  refers  to  the  photo-protective  activity  of  the  food 
supplement, delaying the appearance of UV-induced erythema damages and decreasing its intensity. 
Wording of the health claim as proposed by the applicant 
The applicant has proposed the following wording for the health claim: “helps to prepare sensitive 
skin from the inside to improve their tolerance to the sun”. 
The following alternative wording was proposed: “helps to improve skin tolerance to the sun”. 
Specific conditions of use as proposed by the applicant 
The applicant has proposed a daily intake of 8 mg lycopene, 10 mg vitamin E, 1 mg lutein and 50 µg 
selenium in a food supplement during a meal. The supplementation should start at least one month 
before sun exposure and continue during and after sun exposure. The target population is healthy 
adults in the general population, and in particular people with sensitive skin. 
ASSESSMENT 
1.  Characterisation of the food/constituent 
The food that is the subject of the health claim is a combination of lycopene, vitamin E, lutein and 
selenium. 
The amounts contained in one capsule are: 8 mg lycopene (extracted from tomato), 10 mg vitamin E 
(as  d-alpha-tocopherol),  1 mg  lutein  (extracted  from  Tagetes  erecta  L.)  and  50  µg  selenium  (as 
sodium selenite). Lycopene, vitamin E, lutein and selenium are well-characterised components and 
can be analysed in foods by established methods. 
Information  pertaining  to  the  manufacturing  process,  batch-to-batch  variability  and  control 
specifications has been provided by the applicant. 
The Panel considers that the food, a combination of lycopene, vitamin E, lutein and selenium, which 
is the subject of the health claim, is sufficiently characterised. 
2.  Relevance of the claimed effect to human health 
The claimed effect refers to the photo-protective activity of the food, delaying the appearance of 
UV-induced erythema and decreasing its intensity. The target population proposed by the applicant is 
healthy adults in the general population, and in particular people with sensitive skin. Lycopene, vitamin E, lutein and selenium and 
protection of the skin from UV-induced damage 
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From the information provided, the Panel notes that the claimed effect refers to protection of the skin 
from UV-induced damage, including photo-oxidative damage. 
The Panel considers that protection of the skin from UV-induced (including photo-oxidative) damage 
is a beneficial physiological effect. 
3.  Scientific substantiation of the claimed effect 
The  applicant  performed  a  literature  search  in  Pubmed,  ScienceDirect,  Google,  Google  Scholar, 
IBIDS, Scopus and Scirus using the search terms [(“lutein” AND “lycopene” AND “selenium”) AND 
(“vitamin E”  OR  “tocopherol”)]  AND  (“skin  tolerance”  OR  “dermal  tolerance”  OR  “cutaneous 
tolerance”). Studies were included if they were performed with a combination of ingredients identical 
to the food supplement which is the subject of the health claim. No exclusion criteria were specified. 
The Panel notes the limitations of the literature search performed. 
The applicant identified one human intervention study as being pertinent to the health claim. 
This double-blind, parallel, 10-week study (Béjot et al., 2008) was a bioequivalence study of two oral 
“antioxidant formulas” and their purported protective effects against UV radiation. Fifty Caucasian 
men and women of phototype II or III (sex ratio not specified; age range 18-55 years) took a placebo 
(not specified) for three weeks (i.e. run-in period) and were then randomised to receive for seven 
further  weeks  either  a  supplement  designated  as  “current  formula”  (6 mg  lycopene,  6 mg  beta-
carotene, 10 mg vitamin E and 75 µg selenium; n=25), or the food which is the subject of the health 
claim (“new formula”, n=25). Outcome measures of the study were minimal erythemal dose (MED), 
Individual  Typology  Angle  (i.e.  colorimetric  measurements),  melanin  content  (i.e.  percentage  of 
epidermis occupied by melanin) and “capping” (i.e. assembling of melanosomes at keratinocytes’ 
upper poles). 
The Panel notes that erythema is an inflammatory response of the skin to UV-induced molecular and 
cellular damage. A reduction in UV-induced erythema (e.g. measured as change in MED or erythema 
grade  (reddening))  may  indicate  less  UV-induced  damage  to  the  skin,  but  it  can  also  reflect  a 
reduction  in  the  capacity  of  the  skin  to  react  to  molecular  and  cellular  damage.  Therefore, 
UV-induced erythema cannot be used alone as an outcome measure for the substantiation of  the 
claim. The other outcomes (i.e. Individual Typology Angle, melanin content and “capping”) used in 
the study did not provide any information on UV-induced skin damage. 
The  Panel  notes  that  the  submitted  study  was  a  bioequivalence  study  that  did  not  assess  direct 
measures  of  UV-induced  (including  photo-oxidative)  skin  damage.  The  Panel  considers  that  no 
conclusions can be drawn from this study for the scientific substantiation of the claim. 
The  Panel  notes  that  no  studies  were  provided  from  which  conclusions  could  be  drawn  for  the 
scientific substantiation of the claim. 
The  Panel  concludes  that  a  cause  and  effect  relationship  has  not  been  established  between  the 
consumption of a combination of lycopene, vitamin E, lutein and selenium and protection of the skin 
from UV-induced (including photo-oxidative) damage. 
CONCLUSIONS 
On the basis of the data presented, the Panel concludes that: 
  The food, a combination of lycopene, vitamin E, lutein and selenium, which is the subject of 
the health claim, is sufficiently characterised. Lycopene, vitamin E, lutein and selenium and 
protection of the skin from UV-induced damage 
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  The claimed effect refers to the photo-protective activity of the food, delaying the appearance 
of UV-induced erythema and decreasing its intensity. The target population proposed by the 
applicant is healthy adults in the general population, and in particular people with sensitive 
skin.  Protection  of  the  skin  from  UV-induced  (including  photo-oxidative)  damage  is  a 
beneficial physiological effect. 
  A  cause  and  effect  relationship  has  not  been  established  between  the  consumption  of  a 
combination  of  lycopene,  vitamin E,  lutein  and  selenium  and  protection of the skin from 
UV-induced (including photo-oxidative) damage. 
DOCUMENTATION PROVIDED TO EFSA 
Health claim application on a combination of lycopene, vitamin E, lutein and selenium and protection 
of  the  skin  from  UV-induced  (including  photo-oxidative)  damage  pursuant  to  Article 13(5)  of 
Regulation (EC) No 1924/2006 (Claim serial No: 0355_CY). May 2012. Submitted by Nutrilinks 
Sarl. 
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GLOSSARY / ABBREVIATIONS 
MED    minimal erythemal dose 